Fremanezumab-Vfrm
Brand name: Ajovy Autoinjector
Rank #385 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$24.7M
Total Cost
29,389
Total Claims
$24.7M
Total Cost
1,325
Prescribers
$840
Cost per Claim
1,056
Beneficiaries
35,311
30-Day Fills
$19K
Avg Cost/Provider
22
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$24.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $24.7M total
🔎 Data Overview
Average cost of $23,389 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Fremanezumab-Vfrm
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Robert Pearlman | Neurology | Birmingham, AL | 290 | $219K |
| 2 | Adam Sprouse Blum | Family Practice | Burlington, VT | 126 | $183K |
| 3 | Lance Kim | Neurology | Ocala, FL | 139 | $134K |
| 4 | Franchesca Fiorito-Torres | Neurology | Guaynabo, PR | 164 | $118K |
| 5 | Christina Hatfield | Physician Assistant | Rochester, NY | 116 | $106K |
| 6 | Melissa Johnson | Nurse Practitioner | Ashland, KY | 90 | $106K |
| 7 | Herbert Markley | Neurology | Worcester, MA | 100 | $105K |
| 8 | Michael Zatt | Neurology | Cleveland, OH | 223 | $103K |
| 9 | Barry Vaught | Neurology | Crab Orchard, WV | 87 | $94K |
| 10 | Holly Hasty | Nurse Practitioner | Nashville, TN | 106 | $87K |
| 11 | Laura Hediger | Nurse Practitioner | Springfield, MO | 50 | $83K |
| 12 | Hillary Yu | Nurse Practitioner | Durham, NC | 94 | $83K |
| 13 | Aaron Emmons | Nurse Practitioner | Grand Rapids, MI | 90 | $81K |
| 14 | Reinaldo Verson | Neurology | Columbus, GA | 82 | $80K |
| 15 | Amit Masih | Neurology | Okemos, MI | 92 | $80K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 382 | Glimepiride (Glimepiride) | $25.3M | 1,885,737 |
| 383 | Flecainide Acetate (Flecainide Acetate) | $25.1M | 412,334 |
| 384 | Pioglitazone Hcl (Pioglitazone Hcl) | $24.8M | 1,182,614 |
| 385 | Fremanezumab-Vfrm (Ajovy Autoinjector) | $24.7M | 29,389 |
| 386 | Nitrofurantoin Monohyd/M-Cryst (Nitrofurantoin Mono-Macro) | $24.4M | 1,173,249 |
| 387 | Pegfilgrastim (Neulasta) | $24.4M | 3,096 |
| 388 | Linagliptin/Metformin Hcl (Jentadueto) | $24.3M | 33,018 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology